Quantcast

Health Care Sector Update for 01/10/2019: HALO,PRPO,CGIX


Shutterstock photo

Top Health Care Stocks

JNJ +0.22%

PFE -2.74%

ABT -0.49%

MRK -1.78%

AMGN +1.15%

Health care stocks still were slightly lower this afternoon, including a 0.3% decline for the NYSE Health Care Index in recent trade. Shares of health care companies in the S&P 500 also were down 0.2% as a group, while the Nasdaq Biotechnology index was climbing 0.8%.

Among health care stocks moving on news:

(+) Halozyme Therapeutics ( HALO ) was rising 4% in recent trading after the biotechnology company Wednesday said it expects its FY19 revenue in a range of $175 million to $185 million, excluding any revenue from its new ENHANZE global collaboration and licensing agreements. Analysts, on average, are projecting $153.9 million in revenue for the company this year.

In other sector news:

(+) Precipio ( PRPO ) was 45% higher on Thursday after the cancer diagnostics company said it has been selected as a vendor for the US Department of Defense, allowing Pentagon-funded medical centers to use Precipio technology in mutation testing for both active-duty military and veterans.

(-) Cancer Genetics ( CGIX ) dropped 22% on Thursday after the molecular diagnostics company priced a $3 million public offering of 13.3 million shares of its common stock at 22.5 cents apiece, a discount to its closing price of about 35 cents on Wednesday.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.





This article appears in: Investing , US Markets
Referenced Symbols: HALO , PRPO , CGIX




More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities












Research Brokers before you trade

Want to trade FX?